Pages that link to "Q37216732"
Jump to navigation
Jump to search
The following pages link to The clinical impact of pharmacogenetics on the treatment of epilepsy (Q37216732):
Displaying 50 items.
- The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs (Q26824649) (← links)
- Intercellular transfer of P-glycoprotein in human blood-brain barrier endothelial cells is increased by histone deacetylase inhibitors (Q27332363) (← links)
- Genetic association analysis of ATP binding cassette protein family reveals a novel association of ABCB1 genetic variants with epilepsy risk, but not with drug-resistance (Q28540047) (← links)
- The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies (Q28545116) (← links)
- Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies (Q28546107) (← links)
- Comparison between the Amount of Environmental Change and the Amount of Transcriptome Change (Q28551497) (← links)
- Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy (Q33664128) (← links)
- Genetic testing in the epilepsies--report of the ILAE Genetics Commission (Q33794130) (← links)
- Molecular Genetics of Epilepsy: A Clinician's Perspective (Q33795557) (← links)
- Epilepsy: The future scenario (Q33810221) (← links)
- Expectations, validity, and reality in pharmacogenetics (Q33926313) (← links)
- Drosophila KCNQ channel displays evolutionarily conserved electrophysiology and pharmacology with mammalian KCNQ channels (Q34018870) (← links)
- MDR-1 and MRP2 Gene Polymorphisms in Mexican Epileptic Pediatric Patients with Complex Partial Seizures (Q34312249) (← links)
- Antiepileptic Drug Interactions - Principles and Clinical Implications (Q34402188) (← links)
- Cellular localization and functional significance of CYP3A4 in the human epileptic brain. (Q34669448) (← links)
- Use of Antiepileptic Drugs for Hyperkinetic Movement Disorders (Q34829294) (← links)
- Gene-wide tagging study of the association between KCNT1 polymorphisms and the susceptibility and efficacy of genetic generalized epilepsy in Chinese population. (Q35054372) (← links)
- Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy (Q35072901) (← links)
- Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogenetics (Q35073480) (← links)
- Corpora amylacea deposition in the hippocampus of patients with mesial temporal lobe epilepsy: A new role for an old gene? (Q35073485) (← links)
- Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: a systematic review and meta-analysis (Q35192851) (← links)
- Possible role of CYP2C9 & CYP2C19 single nucleotide polymorphisms in drug refractory epilepsy (Q35351731) (← links)
- Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery (Q35389422) (← links)
- Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis (Q36281662) (← links)
- Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). (Q36907558) (← links)
- Imaging of P-glycoprotein function and expression to elucidate mechanisms of pharmacoresistance in epilepsy (Q36947636) (← links)
- CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents (Q37104987) (← links)
- Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy. (Q37181448) (← links)
- RLIP76 Gene Variants are not Associated with Drug Response in Turkish Epilepsy Patients (Q37181571) (← links)
- Drug treatment of epilepsy: options and limitations (Q37399589) (← links)
- Epilepsy pharmacogenetics (Q37486720) (← links)
- Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients (Q37522302) (← links)
- Association of SCN1A gene polymorphism with antiepileptic drug responsiveness in the population of Thrace, Greece (Q37549339) (← links)
- The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature (Q37587940) (← links)
- Management of the patient with medically refractory epilepsy. (Q37642003) (← links)
- ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics? (Q37658265) (← links)
- Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. (Q37768070) (← links)
- Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again (Q37786731) (← links)
- Transporter Hypothesis of Drug-Resistant Epilepsy: Challenges for Pharmacogenetic Approaches (Q37806763) (← links)
- P-glycoprotein: Tissue Distribution, Substrates, and Functional Consequences of Genetic Variations (Q37811964) (← links)
- Association of ABCB1 Gene Polymorphisms and Their Haplotypes with Response to Antiepileptic Drugs: a Systematic Review and Meta-Analysis (Q37851513) (← links)
- Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction? (Q37855190) (← links)
- Pharmacogenetics of the antiepileptic drugs phenytoin and lamotrigine. (Q37873934) (← links)
- Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions (Q37873936) (← links)
- Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective. (Q37900131) (← links)
- Treatment options for refractory and difficult to treat seizures: focus on vigabatrin (Q37937441) (← links)
- Second-generation antiepileptic drugs and pregnancy: a guide for clinicians. (Q38014890) (← links)
- New avenues for anti-epileptic drug discovery and development (Q38139837) (← links)
- Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs (Q38181565) (← links)
- Association of MDR1 gene C3435T polymorphism with childhood intractable epilepsy: a meta-analysis (Q38189656) (← links)